Advanced search
Publication Cover
Acta Cardiologica Volume 75, 2020 - Issue 5
Submit an article Journal homepage
92
Views
5
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Discrepancy in patterns of myocardial involvement in beta-thalassaemia vs. sickle cell anaemia

Antoine Fakhry AbdelMassihPediatric Cardiology Unit, Pediatrics’ Department, Faculty of Medicine, Cairo University (Kasr Al Ainy), Cairo, Egypt; Correspondence[email protected]
,
Khaled M. SalamaPediatric Hematology Unit, Pediatrics’ Department, Faculty of Medicine, Cairo University (Kasr Al Ainy), Cairo, Egypt;
,
Carolyne GhobrialPediatrics’ Department, Faculty of Medicine, Cairo University (Kasr Al Ainy), Cairo, Egypt
,
Basma HarounPediatrics’ Department, Faculty of Medicine, Cairo University (Kasr Al Ainy), Cairo, Egypt
&
Mohamed Abdel RahmanPediatric Cardiology Unit, Pediatrics’ Department, Faculty of Medicine, Cairo University (Kasr Al Ainy), Cairo, Egypt;
Pages 442-449 | Received 14 Mar 2019, Accepted 18 Apr 2019, Published online: 05 Jun 2019

References

  • Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012;59:1123–1133.
  • Hahalis G, Alexopoulos D, Kremastinos DT, et al. Heart failure in β-thalassemia syndromes: a decade of progress. Am J Med. 2005;118:957–967.
  • Kremastinos DT, Farmakis D, Aessopos A, et al. Beta thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3:451–458.
  • Mansi IA, Rosner F. Myocardial infarction in sickle cell disease. J Natl Med Assoc. 2002;94:448–452.
  • Stanton T, Marwick TH. Assessment of subendocardial structure and function. JACC Cardiovasc Imaging. 2010;3:867–875.
  • Algranati D, Kassab GS, Lanir Y. Why is the subendocardium more vulnerable to ischemia? A new paradigm. AJP Hear Circ Physiol. 2011;300:H1090–H1100.
  • Lekawanvijit S, Chattipakorn N. Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Can J Cardiol. 2009;25:213–218.
  • Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. J Am Soc Echocardiogr. 2003;16:1091–1110.
  • Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277–314.
  • Baksi AJ, Pennell DJ. T2* imaging of the heart. Top Magn Reson Imaging. 2014;23:13–20.
  • Vitrano A, Calvaruso G, Lai E, et al. The era of comparable life expectancy between thalassaemia major and intermedia: is it time to revisit the major-intermedia dichotomy? Br J Haematol. 2017;176:124–130.
  • Wun T, Hassell K. Best practices for transfusion for patients with sickle cell disease. Hematol Rep. 2010;1:22.
  • Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127:750–760.
  • Porter J, Garbowski M. Consequences and management of iron overload in sickle cell disease. Hematology. 2013;2013:447–456.
  • Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107:2279–2285.
  • Bayraktaroǧlu S, Aydinok Y, Yildiz D, et al. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients. Diagnostic Interv Radiol. 2011;17:346–351.
  • Hankins JS, McCarville MB, Hillenbrand CM, et al. Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition. Pediatr Blood Cancer. 2010;55:495–500.
  • Agha HM, Beshlawy A, Hamdy M, et al. Early detection of right ventricular diastolic dysfunction by pulsed tissue Doppler echocardiography in iron loaded beta thalassemia patients. Pediatr Cardiol. 2015;36:468–474.
  • Cusmà Piccione M, Piraino B, Zito C, et al. Early identification of cardiovascular involvement in patients with β-thalassemia major. Am J Cardiol. 2013;112:1246–1251.
  • Parsaee M, Akiash N, Azarkeivan A, et al. The correlation between cardiac magnetic resonance T2* and left ventricular global longitudinal strain in people with β-thalassemia. Echocardiography. 2018;35:438–444.
  • Barbosa MM, Vasconcelos MCM, Ferrari TCA, et al. Assessment of ventricular function in adults with sickle cell disease: role of two-dimensional speckle-tracking strain. J Am Soc Echocardiogr. 2014;27:1216–1222.
  • Blanc J, Stos B, De Montalembert M, et al. Right ventricular systolic strain is altered in children with sickle cell disease. J Am Soc Echocardiogr. 2012;25:511–517.
  • Sengupta SP, Jaju R, Nugurwar A, et al. Left ventricular myocardial performance assessed by 2-dimensional speckle tracking echocardiography in patients with sickle cell crisis. Indian Heart J. 2012;64:553–558.
  • Desai AA, Patel AR, Ahmad H, et al. Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy. Circ Cardiovasc Imaging. 2014;7:430–437.
  • Habara A, Steinberg MH. Minireview: genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood). 2016;241:689–696.
  • Clark NR, Reichek N, Bergey P, et al. Circumferential myocardial shortening in the normal human left ventricle. Assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation. 1991;84:67–74.
  • Freeman GL, LeWinter MM, Engler RL, et al. Relationship between myocardial fiber direction and segment shortening in the midwall of the canine left ventricle. Circ Res. 1985;56:31–39.
  • Enomoto M, Ishizu T, Seo Y, et al. Subendocardial systolic dysfunction in asymptomatic normotensive diabetic patients. Circ J. 2015;79:1749–1755.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.